Comparison of antisense oligonucleotide drug delivery systems
- 1 December 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 100 (3), 411-423
- https://doi.org/10.1016/j.jconrel.2004.08.027
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Physicochemical characterization of protamine-phosphorothioate nanoparticlesJournal of Microencapsulation, 2004
- Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivationJournal of Controlled Release, 2004
- Antisense oligonucleotide treatments for psoriasisExpert Opinion on Biological Therapy, 2004
- Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Phosphorothioate antisense oligodeoxynucleotides: questions of specificityTrends in Biotechnology, 1996
- Delivery of Oligonucleotides and PolynucleotidesJournal of Drug Targeting, 1995
- Reduction of erbB2 Gene-Product in Mamma Carcinoma Cell Lines by erbB2 mRNA-Specific and Tyrosine Kinase Consensus Phosphorothioate Antisense OligonucleotidesBiochemical and Biophysical Research Communications, 1994
- Particle Sizing by Photon Correlation Spectroscopy. Part IV: Resolution of bimodals and comparison with other particle sizing methodsParticle & Particle Systems Characterization, 1993
- Particle Sizing by Photon Correlation Spectroscopy. Part II: Average valuesParticle & Particle Systems Characterization, 1991
- Early events in polyomavirus infection: fusion of monopinocytotic vesicles containing virions with mouse kidney cell nucleiVirus Research, 1988